Events
Search Results
Speaking Engagements
5.13.26
AI at the FDA in HealthTech: Rules, Risks, and the Road Ahead
Join Wilson Sonsini partner Eva Yin on May 13, 2026, as she and fellow panelists participate in a virtual briefing on the intersection of AI and HealthTech at the FDA. The webinar—co-sponsored by Wilson Sonsini, HSBC Innovation Banking, and Healthcare Innovation Catalysts—will offer practical and real-time insights in four areas: the FDA's framework for AI health tech, regulated health tech in practice, legal risk in the gray zone, and the global road ahead.
Affiliated Programs
5.13.26
NSF AHeAD Center Planning Meeting
Wilson Sonsini partner Eva Yin will participate in a planning meeting on artificial intelligence and healthcare hosted by the National Science Foundation AHeAD Center, taking place May 13, 2026, at the University of Florida’s Straughn Center in Gainesville. The meeting is a collaborative effort among the University of Florida, Georgia Tech, Tulane University, and the University of Louisiana at Lafayette.
Speaking Engagements
10.27.25
Seattle AI Week 2025 | Healthcare Inefficiency and Drug Discovery: Reality vs. Hype
Wilson Sonsini partner Eva Yin will join a panel on "Healthcare Inefficiency and Drug Discovery: Reality vs. Hype" at the 2025 Seattle AI Week on October 27, 2025. The panel will explore where healthcare spending is most inefficient and how artificial intelligence is reshaping drug discovery. Panelists will share complementary perspectives—ranging from big-picture analyses of healthcare financing and investor priorities in life sciences and AI, to industry insights on commercializing new therapies. For more information and to register, please visit the event website.
Speaking Engagements
9.10.25
From Lab to Launch: Navigating IVD/LDT Reimbursement, Regulatory, and Investment Hurdles
On September 10, 2025, Wilson Sonsini's Eva Yin, Partner, and Matthew Meyer, Chief Business Advisor, will participate in the “From Lab to Launch” webinar, hosted by GenoSan. Eva will present on FDA regulatory pathways and compliance considerations for diagnostics companies entering the U.S. market. Matthew will offer insights on how life sciences startups can effectively pitch to venture capital firms, drawing on his experience advising diagnostics and biopharma companies. The webinar is designed for innovators, entrepreneurs and industry executives preparing to bring new diagnostic technologies to market. For more information about the event, you can visit the event website.
WSGR Events
5.20.25
Regulatory Outlook Under Trump 2.0: A 100-Day Review
Join us on Tuesday, May 20 for the next session in our webinar series analyzing the shifting U.S. regulatory landscape over the first 100 days of the second Trump administration. Our distinguished panel of former senior regulatory officials will continue their timely conversation on how enforcement and policymaking is evolving across key regulatory areas.
Affiliated Programs
4.23.25
Wilson Sonsini x GHWN - FDA and Business Considerations for Life Sciences and Healthcare Startups
In partnership with Columbia Alumni Association’s Global Health and Wellness Network (GHWN), please join Wilson Sonsini partner Eva Yin for an FDA primer on how medical devices, diagnostics, and pharmaceuticals are regulated, as well as a discussion on general healthcare regulatory considerations and go-to-market strategies for start-ups. The webinar will also feature Chief Business Advisor Matthew Meyer, who will discuss partnering and fundraising best practices for life sciences start-ups.
Speaking Engagements
3.15.25
Digital Fluency: Neurosurgery 2025
On Saturday March 15th, Wilson Sonsini partner Eva Yin will speak at the Digital Fluency: Neurosurgery conference in Palo Alto, CA. She, alongside fellow panelists, will discuss regulatory shifts in technology and AI, including FDA oversight, during their panel, "Rules, Regulations and Uncharted Territory in Ai & Data: Opportunities for Legislative & Oversight Engagement." To learn more about the event and to register, please visit the event website.
Speaking Engagements
2.05.25
Navigating Legal Complexities of AI-Driven SaMD in Health Care
On Wednesday, February 5th, Wilson Sonsini partner Eva Yin will participate in a panel hosted by the American Health Law Association. Exploring the topic “Navigating Legal Complexities of AI-Driven SaMD in Health Care,” Eva and co-panelist Akifa Khattak will discuss the FDA and other regulatory considerations for SaMD and unique challenges facing those adopting AI in healthcare spaces. The session will be held in-person and virtually; to register please visit the event website.
Speaking Engagements
1.25.25
SCBA Life Sciences Panel
On Saturday, January 25th, Wilson Sonsini partner Eva Yin will moderate a panel titled “How to Found a Life Science Startup?” The event, hosted by the SCBA (Seattle Chinese Biomedical Association) and B.E.L.L.E (Boundless; Entrepreneurship; Liberty; Liaison; Empowerment), features founders and investors discussing the ins and outs of establishing a life science start-up. Join with other professionals in the life science field to gain insight into the processes surrounding new and existing ventures. The event is in-person only and registration is free. For more information or to register, click here.